These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38855100)

  • 1. Normalization of eosinophil count is predictive of oxygen weaning over the course of COVID-19 infection among hospitalized adults during the first wave of 2020 pandemic.
    Davido B; Jaffal K; Saleh-Mghir A; Vaugier I; Bourlet S; De Truchis P; Annane D
    Front Immunol; 2024; 15():1381059. PubMed ID: 38855100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eosinophils and Chronic Respiratory Diseases in Hospitalized COVID-19 Patients.
    Valverde-Monge M; Cañas JA; Barroso B; Betancor D; Ortega-Martin L; Gómez-López A; Rodríguez-Nieto MJ; Mahíllo-Fernández I; Sastre J; Del Pozo V
    Front Immunol; 2021; 12():668074. PubMed ID: 34149705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavior of Eosinophil Counts in Recovered and Deceased COVID-19 Patients over the Course of the Disease.
    Cortés-Vieyra R; Gutiérrez-Castellanos S; Álvarez-Aguilar C; Baizabal-Aguirre VM; Nuñez-Anita RE; Rocha-López AG; Gómez-García A
    Viruses; 2021 Aug; 13(9):. PubMed ID: 34578258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inflammatory biomarkers profile of hospitalized patients with COVID-19 and its association with patient's outcome: A single centered study.
    Hachim IY; Hachim MY; Hannawi H; Naeem KB; Salah A; Hannawi S
    PLoS One; 2021; 16(12):e0260537. PubMed ID: 34855832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eosinophil count (EC) as a diagnostic and prognostic marker for infection in the internal medicine department setting.
    Karakonstantis S; Gryllou N; Papazoglou G; Lydakis C
    Rom J Intern Med; 2019 Jun; 57(2):166-174. PubMed ID: 30517081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Peripheral Eosinophil Counts and Eosinophil to Lymphocyte Ratio (ELR) in the Clinical Course of COVID-19 Patients: A Retrospective Study.
    Georgakopoulou VE; Garmpis N; Damaskos C; Valsami S; Dimitroulis D; Diamantis E; Farmaki P; Papageorgiou CV; Makrodimitri S; Gravvanis N; Velonias S; Sklapani P; Trakas N; Antoniou EA; Kontzoglou K; Nikolidakis L; Damaskou Z; Syllaios A; Marinos G; Vogiatzi G; Korrou GE; Kyriakos G; Quiles-Sanchez LV; Patsouras A; Lamprinos D; Stelianidi A; Savvanis S; Garmpi A
    In Vivo; 2021; 35(1):641-648. PubMed ID: 33402521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eosinopenia <100/μL as a marker of active COVID-19: An observational prospective study.
    Outh R; Boutin C; Gueudet P; Suzuki M; Saada M; Aumaître H
    J Microbiol Immunol Infect; 2021 Feb; 54(1):61-68. PubMed ID: 33468435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune Response Dynamics and Biomarkers in COVID-19 Patients.
    Ranjbar M; Cusack RP; Whetstone CE; Brister DL; Wattie J; Wiltshire L; Alsaji N; Le Roux J; Cheng E; Srinathan T; Ho T; Sehmi R; O'Byrne PM; Snow-Smith M; Makiya M; Klion AD; Duong M; Gauvreau GM
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Outcome of Eosinophilia in Patients with COVID-19: A Controlled Study.
    Nair AP; Soliman A; Al Masalamani MA; De Sanctis V; Nashwan AJ; Sasi S; Ali EA; Hassan OA; Iqbal FM; Yassin MA
    Acta Biomed; 2020 Nov; 91(4):e2020165. PubMed ID: 33525219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of high-flow nasal cannula oxygen therapy in treating novel coronavirus pneumonia.
    Teng XB; Shen Y; Han MF; Yang G; Zha L; Shi JF
    Eur J Clin Invest; 2021 Mar; 51(3):e13435. PubMed ID: 33068293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory markers are poorly predictive of clinical outcomes among hospitalized patients with COVID-19.
    Barrett B; Pamphile S; Yang F; Naeem F; Kim J; Annam J; Borczuk R; Yellin S; Bass C; Fowler S; Mosheyev M; Mayer YJ; Friedman BW
    Am J Emerg Med; 2021 Aug; 46():595-598. PubMed ID: 33280969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in eosinophil count during bacterial infection: revisiting an old marker to assess the efficacy of antimicrobial therapy.
    Davido B; Makhloufi S; Matt M; Calin R; Senard O; Perronne C; Dinh A; Salomon J
    Int J Infect Dis; 2017 Aug; 61():62-66. PubMed ID: 28627430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A meta-analysis of SARS-CoV-2 patients identifies the combinatorial significance of D-dimer, C-reactive protein, lymphocyte, and neutrophil values as a predictor of disease severity.
    Singh K; Mittal S; Gollapudi S; Butzmann A; Kumar J; Ohgami RS
    Int J Lab Hematol; 2021 Apr; 43(2):324-328. PubMed ID: 33010111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absolute Eosinophil Count Predicts Intensive Care Unit Transfer Among Elderly COVID-19 Patients From General Isolation Wards.
    Huang J; Zhang Z; Liu S; Gong C; Chen L; Ai G; Zhu X; Zhang C; Li D
    Front Med (Lausanne); 2020; 7():585222. PubMed ID: 33251234
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical characteristics and laboratory biomarkers changes in COVID-19 patients requiring or not intensive or sub-intensive care: a comparative study.
    Cattelan AM; Di Meco E; Trevenzoli M; Frater A; Ferrari A; Villano M; Gomiero F; Carretta G; Sasset L
    BMC Infect Dis; 2020 Dec; 20(1):934. PubMed ID: 33297986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eosinopenia: Is it a good marker of sepsis in comparison to procalcitonin and C-reactive protein levels for patients admitted to a critical care unit in an urban hospital?
    Shaaban H; Daniel S; Sison R; Slim J; Perez G
    J Crit Care; 2010 Dec; 25(4):570-5. PubMed ID: 20435431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of eosinopenia as a diagnostic and prognostic indicator in COVID-19 infection.
    Soni M
    Int J Lab Hematol; 2021 Jul; 43 Suppl 1():137-141. PubMed ID: 33289964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive Value of Eosinophil Count on COVID-19 Disease Progression and Outcomes, a Retrospective Study of Leishenshan Hospital in Wuhan, China.
    Xuan W; Jiang X; Huang L; Pan S; Chen C; Zhang X; Zhu H; Zhang S; Yu W; Peng Z; Su D
    J Intensive Care Med; 2022 Mar; 37(3):359-365. PubMed ID: 34550036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, radiological, and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID-19 patients.
    Zhang JJ; Cao YY; Tan G; Dong X; Wang BC; Lin J; Yan YQ; Liu GH; Akdis M; Akdis CA; Gao YD
    Allergy; 2021 Feb; 76(2):533-550. PubMed ID: 32662525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.